###begin article-title 0
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N-acetyltransferase 8</italic>
###xml 117 127 117 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
N-acetyltransferase 8, a positional candidate for blood pressure and renal regulation: resequencing, association and in silico study
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 230 259 230 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N-acetyltransferase 8 (NAT8) </italic>
Kidneys have an important function in blood pressure (BP) regulation and elevated BP may lead to kidney failure. Chr2p12-p13 region linked to BP traits in multiple studies harbours a potential candidate for BP and renal function, N-acetyltransferase 8 (NAT8) expressed in embryonic and adult kidney and associated with nephrotoxicity response.
###end p 3
###begin title 4
Methods/Results
###end title 4
###begin p 5
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 241 246 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 328 333 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 592 598 589 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8B </italic>
###xml 616 620 613 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8</italic>
###xml 635 639 632 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8</italic>
###xml 737 742 734 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 1159 1167 <span type="species:ncbi:9606">patients</span>
We report the first study exploring NAT8 as a potential candidate gene for blood pressure and kidney function. The resequencing (n = 42, random Estonian samples) identified 15 NAT8 polymorphisms, including 6 novel variants. The diversity of NAT8 5' upstream region (pi/bp = 0.00320) exceeded up to 10 times the variation in the NAT8 genic region (pi/bp = 0.00037) as well as the average variation (pi/bp = 0.00040) for the promoters of 29 reference genes associated with hypertension. We suggest that a potential source for such high variation could be an active gene conversion process from NAT8B duplicate gene to NAT8. Similarly to NAT8, several reference genes with the most variable upstream regions have also duplicate copies. The NAT8 promoter SNPs were targeted with pilot quantitative association studies for blood pressure (n = 137, healthy unrelated individuals) and for the index of kidney function - estimated glomerular filtration rate (eGFR; n = 157 hypertensives with and without nephropathy). Minor alleles of these polymorphisms revealed a significant protective effect against elevated systolic BP as well as kidney failure in hypertension patients (p < 0.05; linear regression model, addictive effect).
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 132 153 132 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N-acetyltransferase 8</italic>
###xml 199 204 199 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 290 300 290 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 374 379 374 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 126 131 <span type="species:ncbi:9606">human</span>
The full resequencing and pilot association study of a novel positional candidate gene for blood pressure and renal function, human N-acetyltransferase 8, suggested a contribution of highly variable NAT8 promoter polymorphisms in determination of systolic blood pressure and eGFR. Based on in silico analysis, we raise the hypothesis that the alternative SNP alleles of the NAT8 upstream region may have differential effect on gene expression.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 554 555 554 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 748 749 748 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 750 751 750 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 948 949 948 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 950 952 950 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 636 644 <span type="species:ncbi:9606">patients</span>
Twin studies have shown that approximately half of the inter-individual variance in blood pressure (BP) level is heritable [1,2]. As distinctive for complex diseases, pathologically high BP diagnosed as essential hypertension (repeated systolic and diastolic BP readings > 140 and/or > 90 mmHg) evolves in association with genetic predisposition and personal life-style. Identification of the mutations behind Mendelian forms leading to hypo- or hypertension has highlighted the central role of the renal metabolic pathways in blood pressure regulation [3]. Consistently, depending on the severity and duration of the hypertension, the patients may develop morphological changes in vasculature of kidneys followed by the progression renal failure [4-6]. In the other way around, it has also been proposed that the defective embryonic development of the kidney or loss of existing nephrons may act as a predisposing factor for primary hypertension [7-10].
###end p 9
###begin p 10
###xml 29 31 29 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 233 245 233 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADD2; SLC8A1</italic>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 676 705 676 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N-acetyltransferase 8 (NAT8) </italic>
###xml 920 922 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1045 1047 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 66 71 <span type="species:ncbi:9606">human</span>
###xml 740 745 <span type="species:ncbi:9606">human</span>
Genome-wide linkage studies [11] have identified the short-arm of human Chr2 as one of the four major genomic regions to be responsible for BP regulation and therefore hold a risk for essential hypertension. Several candidate genes (ADD2; SLC8A1) from this region have been proposed and investigated in detail to play a role in the aetiology of essential hypertension [12,13]. For this study we screened the reported linkage regions at Chr2 for novel BP regulating genes involved in kidney function and renal metabolic pathways. Within the window of 10 Mb from the four reported linkage peaks [11] we have identified at 2p13.1-p12 a novel functionally relevant candidate gene N-acetyltransferase 8 (NAT8) that is highly expressed in normal human embryonic kidney and liver. NAT8 protein has been suggested to play an important role in development and maintenance of the structure and function in adult kidney and liver [14]. Although exact function of the NAT8 is unknown, its expression profile is related to detoxification pathways in kidney [15].
###end p 10
###begin p 11
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 62 67 <span type="species:ncbi:9606">human</span>
In the present study, we have carried out the resequencing of human NAT8 gene followed by a pilot association study of the common NAT8 sequence variation with blood pressure measurements and the index of kidney function. We show that most of the NAT8 variation is harboured in the 5'UTR and upstream regions, which is associated with both, systolic blood pressure levels and the estimated glomerular filtration rate (eGFR).
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Study Population
###end title 13
###begin p 14
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 55 60 <span type="species:ncbi:9606">Human</span>
The study has been approved by the Ethics Committee on Human Research of University of Tartu, Estonia (permissions no 122/13,22.12.2003; 137/20, 25.04.2005). The initial study for resequencing (n = 42) and the association studies (detailed description found below) were carried out using samples of recruited individuals from the Estonian population, classified as a typical North-European population based on its genetic composition [16]. All participating individuals gave their informed consent prior to their inclusion into the study.
###end p 14
###begin title 15
Resequencing
###end title 15
###begin p 16
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 96 101 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 128 134 128 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8B </italic>
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8</italic>
###xml 217 222 217 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 310 321 310 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8/NAT8B </italic>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 487 492 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 523 527 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8</italic>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 682 686 682 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8</italic>
###xml 721 727 721 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8B </italic>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 850 852 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1262 1264 1262 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1327 1332 1327 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 1444 1449 1444 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 1504 1505 1504 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 211 216 <span type="species:ncbi:9606">human</span>
The sequence of the human NAT8 genomic region has been obtained from NCBI GeneBank database. As NAT8 possesses a duplicate gene NAT8B located about 58 Kb downstream from NAT8, the design of the amplification of human NAT8 gene involved two steps (long-range PCR and nested-PCR) (Figure 1a). Alignments between NAT8/NAT8B and their flanking areas (web-based global alignment tool CLUSTALW [17]) revealed a high nucleotide homology between extended genomic regions. The forward primer for NAT8 was positioned within a 313 bp NAT8-specific insertion (Figure 1b). The Primer3 primer designing software [18] was used to search for the matching reverse primer from the region upstream of NAT8, where the sequence homology with NAT8B region did not continue (> 2722 bp upstream; Figure 1b). The uniqueness of long-range PCR primers was checked using BLAST [19]. PCR reactions were performed using Long PCR Enzyme Mix (MBI Fermentas, Vilnius, Lithuania) and Smart-Taq Hot DNA polymerase (Naxo, Estonia) according to the standard protocol recommended by the manufacturers. Detailed conditions for long-range (10341 bp) and nested (2322 bp) PCR, product purification, sequencing, sequence contig assembly and polymorphism identification are described in detail elsewhere [20]. The resequenced region covered 2185 bp including the entire NAT8 (1569 bp) as well as 541 bp of the 5' upstream and 75 bp of the 3' downstream regions. All primers used for the NAT8 PCR amplification and resequencing are listed in Table 1.
###end p 16
###begin p 17
###xml 21 32 21 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8/NAT8B </italic>
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8</italic>
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8B </italic>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8</italic>
###xml 139 145 139 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8B </italic>
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8</italic>
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 0 437 0 437 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) The structure of <italic>NAT8/NAT8B </italic>cluster: <italic>NAT8</italic>/<italic>NAT8B </italic>location in chromosome 2p13.1-p12; (b) Schematic presentation of the alignment of <italic>NAT8</italic>/<italic>NAT8B </italic>and their flanking regions and the positioning of <italic>NAT8</italic>-specific PCR primers; (c) <italic>NAT8 </italic>resequencing results and SNP positions compared to dbSNP database records; (d) Missing Binding Sites for Transcription Factors (TFBS) on chromosomes carrying the minor alleles of SNPs -911, -1151 and -1153.</bold>
(a) The structure of NAT8/NAT8B cluster: NAT8/NAT8B location in chromosome 2p13.1-p12; (b) Schematic presentation of the alignment of NAT8/NAT8B and their flanking regions and the positioning of NAT8-specific PCR primers; (c) NAT8 resequencing results and SNP positions compared to dbSNP database records; (d) Missing Binding Sites for Transcription Factors (TFBS) on chromosomes carrying the minor alleles of SNPs -911, -1151 and -1153. "S" - singleton polymorphisms.
###end p 17
###begin p 18
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8</italic>
###xml 33 38 <span type="species:ncbi:9606">human</span>
PCR and resequencing primers for human NAT8
###end p 18
###begin p 19
###xml 355 551 355 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE, ADD1, ADD2, AGT, AGTR1, AGTR2, KCNJ1, CYP17A1, NPR1, CLCNKA, HSD11B1, CYP11B2, CLCNKB, KLK1, NPR2, BSND, NR3C2, CYP21A2, SAH, SGK, SLC12A3, SCNN1A, IL1A, SLC14A2, SLC22A2, REN, ATP1A, SCNN1B </italic>
###xml 555 562 555 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC8A1 </italic>
###xml 622 623 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
In the extended association study of the 5'upstream SNPs, only the sequencing primers 4F and 4R were used. For the comparison of sequence diversity parameters, we resequenced (n = 14) the promoter regions (+100 bp up to -500 bp relative to mRNA transcription initiation site) for 29 previously established blood pressure associated genes from literature: ACE, ADD1, ADD2, AGT, AGTR1, AGTR2, KCNJ1, CYP17A1, NPR1, CLCNKA, HSD11B1, CYP11B2, CLCNKB, KLK1, NPR2, BSND, NR3C2, CYP21A2, SAH, SGK, SLC12A3, SCNN1A, IL1A, SLC14A2, SLC22A2, REN, ATP1A, SCNN1B and SLC8A1 (primers used for PCR and resequencing, see additional file 1: Primers).
###end p 19
###begin title 20
Subjects for Association Studies
###end title 20
###begin title 21
Association study for blood pressure
###end title 21
###begin p 22
###xml 236 238 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 369 371 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1299 1311 <span type="species:ncbi:9606">participants</span>
Long-term blood donors (n = 137; 76 males, 61 females; age 40 +/- 7.8 years; BMI 25 +/- 2.6) were recruited in the framework of HYPEST study (participation rate 51.5%; Org et al., unpublished data) from the North Estonian Blood Center [21] coordinating the blood donation in northern, eastern, and western Estonia, and the Blood Centre of the Tartu University Clinics [22] coordinating the blood donation activity in central and southern Estonia. The exclusion criteria for donors included cardiovascular diseases, diabetes and antihypertensive treatment ascertained by confidential self-reported signed questionnaires and medical examination. Both Blood Centres have standardized protocols for measuring blood pressure by responsible trained clinicians. After a rest in a sitting position, the blood pressure reading of a donor was obtained during each visit to the Blood Donation Centre. All recruited individuals possess a documented history of multiple systolic and diastolic blood pressure (SBP, DBP) readings (on average 4 readings per individual, range 2-14) during 3 +/- 2.5 years (range 1-7 years). Most of the BP measurements per subject have been obtained using a standard mercury column sphygmomanometer and size-adjusted cuffs. Occasionally, outside of blood donation centres BP of the participants was measured by oscillometric method using NAIS DIAGNOSTEC blood pressure watch (Matsushita Electronic Works) after a rest in a sitting position and with the arm placed at the heart level. No systematic deviation was observed between the two devices. The BP parameters across the whole cohort study group were as following: SBP 134.2 +/- 11.5 mmHg within a range of 113.5 - 171 mmHg; and DBP 84.6 +/- 7.6 mmHg within a range of 65.5 - 110 mmHg. Quantitative analysis was performed with a calculated median of a subject's BP readings adjusted to age and sex as co-variables.
###end p 22
###begin title 23
Association study for estimated glomerular filtration rate (eGFR)
###end title 23
###begin p 24
###xml 57 65 <span type="species:ncbi:9606">patients</span>
###xml 324 332 <span type="species:ncbi:9606">patients</span>
The study group of long-term essential hypertension (EH) patients (n = 157; 78 males, 79 females; age at the time of EH diagnosis 47 +/- 9.7 years; age at recruitment 59 +/- 9 years; BMI 28 +/- 3.8) without and with hypertensive nephropathy were recruited (participation rate 42.3%) by blood pressure specialists during the patients' ambulatory visit or hospitalization at the North Estonia Medical Center, Centre of Cardiology (cardiologist M.V.) or at the Cardiology (coordinated by G.V.) and Internal Medicine Clinics (nephrologist M.R.), Tartu University Hospital, Estonia. The selection criteria for the study group were as following:
###end p 24
###begin p 25
- Long term (mean duration 12.5 y) essential hypertension diagnosed by a clinical specialist (SBP > 140 mmHg, DBP > 90 mmHg).
###end p 25
###begin p 26
###xml 15 23 <span type="species:ncbi:9606">patients</span>
- Exclusion of patients with diabetes and primary renal failure by a clinical specialist
###end p 26
###begin p 27
###xml 29 37 <span type="species:ncbi:9606">patients</span>
- All recruited hypertension patients received antihypertensive treatment
###end p 27
###begin p 28
###xml 252 268 252 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per exclusionem </italic>
###xml 277 285 <span type="species:ncbi:9606">patients</span>
Diagnose of hypertensive nephropathy was assigned by nephrologists (M.R.) based on longstanding blood pressure elevation together with proteinuria and presence of progressive chronic kidney disease. Differential diagnosis was established using methods per exclusionem i.e. the patients possessed no symptoms of glomerulonephritis, systemic diseases, amyloidosis or other glomerulopathies, confirmed by diagnostic labororatory tests.
###end p 28
###begin p 29
###xml 250 254 250 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 354 356 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 435 437 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 537 539 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 616 618 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 686 688 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
The venous blood for serum biomarker analysis was drawn in the morning after an overnight fast. Urea (measurement uncertainty 9.7%), creatinine (m.u. 17.2%) and albumine (m.u. 6.9%) in the serum were measured by standardized assays (Cobas Integra 800(R) analytical platform, Roche Diagnostics, Inc.) at the United Laboratories, Tartu University Clinics [22] or at the Diagnostics Division Laboratory, the North Estonia Medical Centre [23]. The tests of for the serum biomarkers have been accredited by the Estonian Accreditation Centre [24] according to the standards of the European co-operation for Accreditation [25]. Measurement uncertainty was estimated using EURACHEM guidelines [26]. It is defined as the parameter associated with the result of a measurement that characterizes the dispersion of the values that could reasonably be attributed to the measurand (e.g. the concentration of a biomarker).
###end p 29
###begin p 30
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 275 278 275 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Cr </sub>
Kidney function was evaluated using estimated glomerular filtration rate (eGFR), the most recommended overall index of kidney function in health and disease [27]. The formula [28] includes both, demographic (age, sex, race) and blood serum (urea - SUN [mg/dl], creatinine - PCr [mg/dl], albumin - Alb [g/dl]) variables.
###end p 30
###begin p 31
###xml 19 20 19 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 31 33 31 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Cr</sub>
###xml 34 41 34 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-0,999 </sup>
###xml 48 55 48 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-0,176 </sup>
###xml 93 99 93 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-0,17 </sup>
###xml 106 112 106 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+0,318</sup>
###xml 67 74 <span type="species:ncbi:9606">patient</span>
eGRF (ml/min/1,73 m2) = 170x (PCr)-0,999 x (Age)-0,176 x (0,762 if patient is female) x (SUN)-0,17 x (Alb)+0,318
###end p 31
###begin p 32
###xml 41 43 41 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
A decrease of eGFR below 60 ml/min/1.73 m2 precedes the onset of kidney failure (K/DOQI 2002). The distribution of eGFR values for our study population was 72 +/- 28.5 (range 5 - 143).
###end p 32
###begin title 33
Statistical analysis
###end title 33
###begin p 34
###xml 93 103 93 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
Methods used for Hardy-Weinberg equilibrium estimations, sequence diversity calculations and in silico prediction of transcription factor binding sites are described in detail elsewhere [29,30]. Quantitative genetic association analyses for blood pressure and serum biomarkers were performed with association analysis toolset PLINK [31]. Association was tested using linear regression analysis with additive effect model and likelihood-ratio test (LRT) with age, sex and BMI as co-variables. Statistical significance for the different distribution of the quantitative measurements (BP, GFR) in two subgroups based on the genotype was verified using non-parametric Mann-Whitney two-sided U-test performed with a web-based interface [32]. In all computed statistical tests a p-value < 0.05 was considered statistically significant and p < 0.1 as suggestive.
###end p 34
###begin title 35
Results
###end title 35
###begin title 36
Detailed diversity patterns of NAT8 by resequencing
###end title 36
###begin p 37
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 98 119 98 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N-acetyltransferase 8</italic>
###xml 249 253 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8</italic>
###xml 426 427 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 876 877 876 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 910 978 910 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pan troglodytes, Mus musculus, Rattus norvegicus, Xenopus tropicalis</italic>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 910 925 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 927 939 <span type="species:ncbi:10090">Mus musculus</span>
###xml 941 958 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 960 978 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 999 1004 <span type="species:ncbi:9606">human</span>
To uncover the detailed genetic variation of a putative human blood pressure candidate gene NAT8 (N-acetyltransferase 8; 2p13.1-p12) we resequenced the gene in a random Estonian population sample (n = 42). The analyzed region (1569 bp of the entire NAT8; 541 bp of 5' upstream and 75 bp of 3' downstream) harboured 15 SNPs including 10 rare (Minor allele frequency, MAF < 10%) and five common (MAF > 10%) polymorphisms (Table 2). Nine SNPs (n = 6 in 5'upstream region; n = 1 in intron 1, exon 2 and 3'downstream region) were previously characterized in dbSNP database, including five HAPMAP SNPs (rs482951, rs2280506, rs2280507, rs6744273, rs13538). Six rare variants are novel, neither represented in dbSNP nor reported elsewhere: one SNP in untranslated exon 1, one in intron 1 and four nonsynonymous substitutions in exon 2. The alignment of NAT8 protein sequences (Figure 2) of several vertebrate species (Pan troglodytes, Mus musculus, Rattus norvegicus, Xenopus tropicalis) indicated that the human polymorphic amino acid positions are not conserved in evolution. Thus we did not include these SNPs for further association study.
###end p 37
###begin p 38
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
NAT8 genomic region SNPs identified by resequencing in random Estonian population samples (n = 42)
###end p 38
###begin p 39
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAF</italic>
###xml 44 45 44 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
Abbreviations: MAF, minor allele frequency; S, singletons
###end p 39
###begin p 40
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aLocation relative to ATG
###end p 40
###begin p 41
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
bMajor/minor allele
###end p 41
###begin p 42
###xml 44 56 44 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homo sapiens</italic>
###xml 61 76 61 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pan troglodytes</italic>
###xml 81 93 81 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus</italic>
###xml 98 115 98 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rattus norvegicus</italic>
###xml 119 137 119 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis</italic>
###xml 0 138 0 138 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The alignment of NAT8 protein sequences: 1- <italic>Homo sapiens</italic>, 2- <italic>Pan troglodytes</italic>, 3- <italic>Mus musculus</italic>, 4- <italic>Rattus norvegicus</italic>, 5-<italic>Xenopus tropicalis</italic>.</bold>
###xml 44 56 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 61 76 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 81 93 <span type="species:ncbi:10090">Mus musculus</span>
###xml 98 115 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 119 137 <span type="species:ncbi:8364">Xenopus tropicalis</span>
The alignment of NAT8 protein sequences: 1- Homo sapiens, 2- Pan troglodytes, 3- Mus musculus, 4- Rattus norvegicus, 5-Xenopus tropicalis. Arrows pointing at polymorphic amino acid positions (14 Arg-His, 73 Ala-Val, 121 Met-Thr, 130 Pro-Pro, 143 Phe-Ser).
###end p 42
###begin p 43
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c</xref>
###xml 249 254 249 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 277 283 277 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8B </italic>
###xml 366 371 366 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 375 381 375 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8B </italic>
###xml 410 411 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
The NAT8 resequencing data deviated strongly from the polymorphism pattern in public dbSNP database [33] with 39 SNP entries for NAT8 region (Figure 1c). The higher number of SNPs in dbSNP might represent paralogous sequence variants (PSVs) between NAT8 and its duplicate gene NAT8B as all the unidentified dbSNP entries co-located with the sequence positions where NAT8 and NAT8B diverge (see additional file 2: Alignment).
###end p 43
###begin p 44
###xml 113 118 112 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 265 267 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 316 317 312 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 333 334 329 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 560 562 546 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T </sup>
###xml 589 594 575 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 634 636 620 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T </sup>
###xml 736 741 722 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 835 836 820 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 854 856 839 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T </sup>
###xml 929 934 914 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 1217 1222 1202 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 1229 1230 1214 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 1256 1261 1241 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 1615 1619 1597 1601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8</italic>
###xml 1676 1698 1658 1680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP11B2, IL1A, SLC14A2</italic>
Direct estimation of per-site heterozygosity (pi) was derived from the average pairwise sequence difference. The NAT8 gene (1569 bp; pi/bp = 0.00037) and mRNA (953 bp; (pi/bp = 0.00045) exhibit two times lower sequence diversity compared to a data set of 74 genes [34] (pi/bp = 0.00080 for European Americans; Table 3). Tajima's D (DT) statistic was used to estimate the difference between the parameters pi and theta, representing the expected per-site heterozygosity based on the number of segregating sites. In case of neutrality, pi equals theta and thus DT statistic equals zero. For NAT8 coding region, the calculated negative DT values refer to the excess of rare SNPs suggesting a purifying selection pressure. In contrast, the NAT8 5'upstream region exhibits approximately eight times higher diversity (pi/bp = 0.00320; Table 3) and a positive DT value indicating an excess of common SNPs. Accordingly, four of the five NAT8 SNPs with minor allele frequency > 10% are located in the upstream region. Notably, this high diversity is uncommon in the dataset of promoter regions (+100 bp to -500 bp relative to mRNA transcription start) of 29 previously studied blood pressure genes resequenced to compare with NAT8 (Table 3). The diversity level of NAT8 upstream area (6 SNPs) exceeded about eight times the average of 29 reference genes (pi/bp = 0.00320 versus pi/bp = 0.0004). Of the 29 studied gene upstream regions, 17 (59%) had no SNPs, in the rest of the genes (n = 12) the number of SNPs ranged from one to four with the heterozygosity parameter (pi) being 0.00023-0.0017. Interestingly, similarly to NAT8, several genes with the most variable upstream regions (CYP11B2, IL1A, SLC14A2) have also duplicate copies.
###end p 44
###begin p 45
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
Diversity parameters for resequenced NAT8 gene and promoter regions of 29 genes associated with blood pressure determination
###end p 45
###begin p 46
###xml 15 17 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#960;</italic>
###xml 113 118 112 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#952;</italic>
###xml 196 197 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 197 198 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 197 198 192 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>T</italic></sup>
Abbreviations: pi, estimate of nucleotide diversity per site from average pairwise difference among individuals; theta, estimate of nucleotide diversity per site from number of segregating sites; DT, value of Tajima's D statistics expressing the difference between pi and theta estimates
###end p 46
###begin p 47
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aRegion between -500 bp and +100 bp relative to mRNA transcription start point
###end p 47
###begin p 48
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 83 201 83 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE, ADD1, ADD2, AGT, AGTR2, KCNJ1, NPR1, HSD11B1, CLCNKB, KLK1, NR3C2, CYP21A2, SLC22A2, REN, ATP1A1, SCNN1B, SLC8A1 </italic>
bNo SNPs were detected in Estonian sample by resequencing the promoter regions for ACE, ADD1, ADD2, AGT, AGTR2, KCNJ1, NPR1, HSD11B1, CLCNKB, KLK1, NR3C2, CYP21A2, SLC22A2, REN, ATP1A1, SCNN1B, SLC8A1 genes
###end p 48
###begin title 49
Association study of NAT8 5' upstream SNPs with blood pressure and eGFR
###end title 49
###begin p 50
###xml 2 7 2 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 762 767 762 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 908 909 908 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 1441 1443 1437 1439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 1601 1606 1597 1602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
A NAT8 5'upstream putative promoter region [SNPs -1255 (T/C), rs4852954; -1153 (A/G), rs4852953; -1152 (C/T), rs4852952; -1041 (G/C), rs4852951; -911 (T/C), rs2280506 and -803 (C/T), rs2280507] was targeted in association studies for BP and estimated glomerular filtration rate (eGFR). Despite close vicinity, these SNPs form two distinct allelic association blocks: from -1225 to -1041 and from -911 to -365 (Figure 3). Notably, the latter region is also in LD with the 3' downstream SNP (+859 G/A; rs1879662). We used median values of systolic and diastolic blood pressure (SBP, DBP) readings in a cohort of long-term healthy Estonian donors (n = 137) with no history of cardiovascular diseases and respective treatments. SBP was significantly associated with NAT8 SNPs -803 (C/T) and -911 (T/C) using LRT (p = 0.028) and linear regression model (additive effects of allele dosage; p = 0.015) tests (Table 4). The significant negative regression coefficient (-5.034) referred to the association of the minor alleles of SNP -803/-911 with lower SBP values and indicated that these variants may possess a potential protective effect towards hypertension. Indeed SBP was significantly (p = 0.04; Mann-Whitney U test) lower by average 5 mmHg for the carriers of the minor alleles (median 131 mmHg; mean 130.5 +/- 10.0; n = 33) compared to the major allele homozygotes (median 135 mmHg; mean 135.5 +/- 11.7; n = 104) for SNPs -803/-911 (Figure 4a), supporting a protective effect of these alleles against blood pressure elevation. Association analysis of SBP with other upstream SNPs and of DBP with any NAT8 SNPs did not reveal any statistical significance (p = 0.1).
###end p 50
###begin p 51
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
P-values from association tests of NAT8 upstream SNPs: linear regression (additive model) adjusted for age, gender and BMI
###end p 51
###begin p 52
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SBP</italic>
###xml 45 48 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DBP</italic>
###xml 78 81 78 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFR</italic>
###xml 121 131 121 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink">p &lt; 0.05; </bold>
###xml 131 140 131 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p &#8804; 0.1</italic>
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; e GFR, estimated glomerular filtration rate; p < 0.05; p </= 0.1.
###end p 52
###begin p 53
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">LD structure of the resequenced <italic>NAT8 </italic>genomic region shown as r<sup>2</sup>-blot.</bold>
###xml 165 170 165 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
LD structure of the resequenced NAT8 genomic region shown as r2-blot. Upper white bar depicts the positions of identified SNPs (Table 2) relative to the location of NAT8 gene ATG (A denoted as +1). Singleton polymorphisms were excluded from calculations.
###end p 53
###begin p 54
###xml 210 215 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 0 229 0 229 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Notched box plots for the distribution of (a) systolic blood pressure (SBP) readings; and (b) estimated glomerular filtration rate (GFR) values for the major allele homozygotes and the minor allele carriers of <italic>NAT8 </italic>promoter SNPs.</bold>
###xml 256 259 256 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 265 268 265 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
Notched box plots for the distribution of (a) systolic blood pressure (SBP) readings; and (b) estimated glomerular filtration rate (GFR) values for the major allele homozygotes and the minor allele carriers of NAT8 promoter SNPs. The boxes represent the 25th and 75th percentiles. The median is denoted as the line that bisects the boxes. The whiskers are lines extending from each end of the box covering the extent of the data on 1.5 x interquartile range. Circles represent the outlier values. P-values from Mann-Whitney U-test are shown, applied to test the statistical difference in the distributions of SBP or GFR estimates between two groups.
###end p 54
###begin p 55
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 395 400 393 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 486 487 484 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 1036 1038 1026 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
###xml 188 196 <span type="species:ncbi:9606">patients</span>
We further tested the association of NAT8 upstream SNPs with the reduction of kidney function as a consequence of essential hypertension using an Estonian cohort of long-term hypertension patients without and with hypertensive nephropathy. Linear regression analysis (additive model) and LRT test detected significant (SNP-803 and SNP-1041; p < 0.05) and borderline (p </= 0.08) associations of NAT8 upstream SNPs with eGFR estimates reflecting the efficiency of kidney function (Table 4). Significant positive linear regression coefficients indicated the association of SNP-803 (10.7) and SNP-1041 (6.4) with higher GFR values. The distribution of eGFR values for heterozygotes of SNP -803 (median 83.3; mean 82 +/- 21.5; n = 33) and SNP -1041 (median 80.5; mean 77 +/- 28; n = 90) was significantly higher (Mann-Whitney U test, p = 0.04 and p = 0.02) than for wild-type homozygotes (SNP -803: median 71.9; mean 70 +/- 29.7, n = 124; SNP -1041: median 68.3; mean 66 +/- 28; n = 67) on average 12 and 11 GFR units, respectively (Figure 4b).
###end p 55
###begin title 56
Functional significance of NAT8 5'upstream SNP alleles
###end title 56
###begin p 57
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 96 106 96 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 378 383 378 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1d</xref>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 847 849 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 947 949 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1337 1339 1337 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1220 1226 <span type="species:ncbi:9606">humans</span>
Possible functional significance of NAT8 upstream SNP alternative alleles was targeted with the in silico transcription factor binding site (TFBS) prediction using MatInspector [35] software. Several potential TFBSs within predicted classical promoter region (+100 to -500 bp relative to mRNA transcription start) are missing on the chromosomes that carry the minor alleles for NAT8 upstream SNPs -911 (major allele T/minor allele C), -1152 (C/T) and -1153 (A/G) (Figure 1d). Compared to the common T variant, the C allele of SNP -911 lacks potential binding sites for seven competing or co-activating TFs, including factors involved in inflammatory, cardiovascular or renal function: oestrogen related receptor (ERR) [36], RAR-related orphan receptor alpha1 (RORA) [37], HMG box-containing protein 1 (HBP1) [38], nuclear factor kB (NF-kB)/c-rel [39]. Allele- specific binding of ERR was confirmed by another TFBS prediction program AliBaba 2.1. [40]. Minor combinatory variant (T-G) for neighbouring SNPs -1152/-1153 miss two potential TFBSs, one for serum response factor (SRF) and the other for myeloid zinc finger protein (MZF1) located on the opposite strands. SRF is a transcription factor conserved from flies to humans and shown to regulate coordinated gene expression in cardiac and vascular smooth muscle cell differentiation [41].
###end p 57
###begin title 58
Discussion
###end title 58
###begin p 59
###xml 42 64 42 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N-acetyltransferase 8 </italic>
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8</italic>
###xml 172 177 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 310 315 310 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 522 523 522 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 674 675 674 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 255 260 <span type="species:ncbi:9606">human</span>
###xml 739 744 <span type="species:ncbi:9606">human</span>
We report the first study targeting human N-acetyltransferase 8 (NAT8) as a potential blood pressure (BP) and kidney function associated gene. Although the knowledge about NAT8 is scarce, it was shown to be highly expressed in developing as well as adult human kidney and liver [14]. A recent study associated NAT8 expressional profile with nephrotoxicity response [15]. Kidney function has been associated with BP from two complimentary viewpoints: (1) link between elevated blood pressure and risk for kidney failure [4,6]; and (2) link between renal structural/functinonal abnormalities developed during intrauterine life as susceptibility to hypertension in adult life [7,10]. In listing the candidate genes for association studies of human blood pressure traits, the genes protecting and contributing to normal fetal renal programming have often been overlooked as potential susceptibility factors.
###end p 59
###begin p 60
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 635 643 635 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP11B2 </italic>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 652 657 652 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPR1 </italic>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 677 684 677 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCNN1A </italic>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 693 697 693 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGT </italic>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
We showed that the putative upstream NAT8 promoter region is highly diverse compared to the gene's coding region, as well as to the promoters of BP-associated reference genes resequenced for comparison. High diversity may indicate the lack of selective constraint and/or the maintenance of several functioning promoter variants with differential effect on gene expression. For a number of genes shown to contribute to blood pressure regulation, the promoter polymorphisms have been associated with the diagnosis of hypertension. Examples of experimentally confirmed differential effects of alternative alleles on promoter activity are CYP11B2 [42-44], NPR1 (reviewed in [45]), SCNN1A [46] and AGT [47].
###end p 60
###begin p 61
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 954 959 954 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 1566 1568 1566 1568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 208 216 <span type="species:ncbi:9606">patients</span>
In a pilot association study based on a random Estonian population cohort we identified an association between NAT8 promoter SNPs and systolic BP. Consistently, in a separate cohort of essential hypertension patients the same markers showed association with estimated glomerular filtration rate (eGFR). Interestingly, the minor alleles of the same SNPs reveal protective effects towards both, the elevated BP and the risk of kidney failure as the complication to high blood pressure. We are aware that the results of these pilot association studies may be biased due to phenotypic misclassification and/or may be underpowered due to limited sample sizes. Also, multiple testing tends to inflate type 1 error rates. Another limitation may be the lack of sensitivity of the eGFR calculations based on serum creatinine instead of the actual GFR values obtained from measurements using an exogenous filtration marker. Thus, replication of the association of NAT8 with SBP and eGFR in other study populations, as well as functional experiments addressing the effect of the alternative promoter variants are required to ultimately determine the role of this gene in blood pressure regulation and kidney function. While evaluating the data from the association studies, one also has to keep in mind that both BP regulation and kidney metabolic function are complex traits determined by the combination of environmental, individual's life style and heterogenous genetic factors and thus the contribution of each gene variant is expected to be small. Recently, Yamada et al [48] performed a large association study with 150 SNPs in 128 functionally relevant BP regulating genes for 2818 hypertensive Japanese and 2035 matched controls. Using multivariable logistic regression analysis, significant associations (0.002 < p < 0.05) with hypertension were detected only with 10% (n = 15) of the targeted SNPs. Interestingly, seven of these were promoter variants and in 10 SNPs out of the significant 15 the carrier status of the minor allele provided a protective effect against blood pressure elevation.
###end p 61
###begin p 62
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8B </italic>
###xml 81 87 81 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8B </italic>
###xml 236 242 236 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8B </italic>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 456 460 456 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8</italic>
###xml 541 547 541 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8B </italic>
###xml 142 145 <span type="species:ncbi:4456">ape</span>
###xml 173 183 <span type="species:ncbi:9598">chimpanzee</span>
###xml 230 235 <span type="species:ncbi:9606">human</span>
###xml 272 277 <span type="species:ncbi:9606">human</span>
High homology between NAT8 and its pseudogene NAT8B is due to a recent origin of NAT8B through the duplication of an ancestral gene after the ape-Old World monkey split. In chimpanzee both gene copies are still active, whereas in human NAT8B appears to be inactive due to human-specific nonsense mutations [49]. There are multiple examples of gene conversion events between genes and their pseudogenes causing the dysfunction of the genes [50]. In case of NAT8, the alternative promoter sequence may have arisen through gene conversion from NAT8B leading to differentially expressed gene variants.
###end p 62
###begin p 63
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 686 691 686 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 731 733 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 801 806 801 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 1044 1049 1044 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 1106 1111 1106 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 1659 1661 1659 1661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 608 613 <span type="species:ncbi:9606">human</span>
Although the exact function of NAT8 is still to be determined, it has recently been shown to participate in detoxification processes of TCE (trichloroethylene) metabolite DCVC (S-(1,2-dichlorovinyl)-L-cysteine) in the kidney. DCVC detoxification in kidneys has two alternative metabolic pathways: (1) bioactivation through B-lyase activity leading to the accumulation of a nephrotoxic reactive sulfhydryl-intermediate (DCVSH - dichlorovinyl mercaptan) and (2) N-acetylation of DCVC resulting in a harmless acetylated product (NacDCVC - N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine) excreted in urine [51]. When human renal proximal tubule cells were exposed to low concentrations of DCVC, NAT8 expression was reduced more than twice [15]. We hypothesize that the transcriptional activation of the common NAT8 promoter variant is repressible by toxic substances (e.g. TCE metabolites) and reduction of N-acetylation activity may lead to favouring of the nephrotoxic pathway. Due to differential cocktail of activating transcription factors for the NAT8 promoter variant with alternative SNP alleles, the minor NAT8 variant may be less sensitive to transcriptional suppression and the carriers may be better protected for the nephrotoxicity. The two disease processes, renal response to nephrotoxins and the pathogenesis of hypertension may be connected through overlapping physiological pathways. A representative example is the enzyme haem oxigenase 1 (HO-1) responsible for the catabolism of free heam, being induced in some models of hypertension as well as up-regulated in a variety of kidney injury models, including the effect of nephrotoxins (reviewed in [52]).
###end p 63
###begin title 64
Conclusion
###end title 64
###begin p 65
###xml 132 153 132 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N-acetyltransferase 8</italic>
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 324 334 324 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 408 413 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 126 131 <span type="species:ncbi:9606">human</span>
The full resequencing and pilot association study of a novel positional candidate gene for blood pressure and renal function, human N-acetyltransferase 8, suggested the contribution of highly variable NAT8 promoter polymorphisms in determination of systolic blood pressure and estimated glomerular filtration rate. Based on in silico analysis, we raise the hypothesis that the alternative SNP alleles within NAT8 upstream region may have differential effect on gene expression.
###end p 65
###begin title 66
Competing interests
###end title 66
###begin p 67
The author(s) declare that they have no competing interests.
###end p 67
###begin title 68
Authors' contributions
###end title 68
###begin p 69
PJ designed the study, performed resequencing, and contributed to the analysis and interpretation of the data as well as to writing of the manuscript. EO, MV, GV and MR recruited hypertensive individuals for the study, collected the epidemiological data, and revised the manuscript since its early versions. EO, KK, GV and PK assisted in collection of long-term blood donors, preparation of the DNA samples and laboratory experiments. ML contributed in outlining the study design and directing research, participated in the data analysis and drafted the manuscript. All authors read and approved the final manuscript.
###end p 69
###begin title 70
Pre-publication history
###end title 70
###begin p 71
The pre-publication history for this paper can be accessed here:
###end p 71
###begin p 72

###end p 72
###begin title 73
Supplementary Material
###end title 73
###begin title 74
Additional file 1
###end title 74
###begin p 75
PCR and resequencing primers for the promoter regions (+100 bp up to -500 bp relative to mRNA transcription initiation site) of 29 genes associated with blood pressure determination.
###end p 75
###begin p 76
Click here for file
###end p 76
###begin title 77
Additional file 2
###end title 77
###begin p 78
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8B</italic>
###xml 420 425 420 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 429 434 429 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8B</italic>
###xml 465 470 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAT8 </italic>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 459 464 <span type="species:ncbi:9606">human</span>
Nucleotide sequence alignment between human NAT8 gene and its duplicated pseudogene NAT8B. The alignment includes the entire gene along with 541 bp of 5' upstream and 700 bp of 3' downstream regions. Untranslated mRNA and protein-coding regions are marked with thin and bold lines, respectively. Nucleotides typed in bold indicate SNPs detected by resequencing and their position relative to ATG. Divergent positions in NAT8 and NAT8B, which co-localize with human NAT8 SNPs in NCBI dbSNP, are boxed.
###end p 78
###begin p 79
Click here for file
###end p 79
###begin title 80
Acknowledgements
###end title 80
###begin p 81
We thank Drs Aleksei Teor and Karel Tomberg; Anne Speek and Aino Hallik from North Estonia Medical Centre, Tallinn, Estonia; Drs Sirly Tikas, Riho Paesuld and Tatjana Plahhova from North Estonian Blood Center; the personnel and especially Dr Ulle Kuusik from the Blood Center of Tartu University Clinics; Kersti Kivi, Kulli Kangur, Dr Tiina Ristimae from the Department of Cardiology and Dr Kulli Kolvald from the Department of Internal Medicine, University of Tartu Clinics; Tiina Rebane, Kart Tomberg and Margus Putku for assistance in subject recruitment in the framework of HYPEST study. Viljo Soo is acknowledged for technical assistance in DNA sequencing, and Tonu Margus for bioinformatics support. M.L. is a Wellcome Trust International Senior Research Fellows (grants no. 070191/Z/03/Z) in Biomedical Science in Central Europe and HHMI International Scholar (grant #55005617). Additionally, the study has been supported by Estonian Ministry of Education and Science core grant no. 0182721s06 and Estonian Science Foundation grant no. 5796.
###end p 81
###begin article-title 82
Twins in cardiovascular genetic research
###end article-title 82
###begin article-title 83
Heritability of blood pressure and hemodynamics in African- and European-American youth
###end article-title 83
###begin article-title 84
###xml 24 29 <span type="species:ncbi:9606">human</span>
Molecular mechanisms of human hypertension
###end article-title 84
###begin article-title 85
###xml 46 49 <span type="species:ncbi:9606">men</span>
Blood pressure and end-stage renal disease in men
###end article-title 85
###begin article-title 86
Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?
###end article-title 86
###begin article-title 87
Primary hypertension and nephropathy
###end article-title 87
###begin article-title 88
Glomeruli and blood pressure. Less of one, more the other?
###end article-title 88
###begin article-title 89
Kidney development and the fetal programming of adult disease
###end article-title 89
###begin article-title 90
Reduced nephron number, renal development and 'programming' of adult hypertension
###end article-title 90
###begin article-title 91
Adult hypertension and kidney disease: the role of fetal programming
###end article-title 91
###begin article-title 92
Genome scans for hypertension and blood pressure regulation
###end article-title 92
###begin article-title 93
Association of the alpha-adducin locus with essential hypertension
###end article-title 93
###begin article-title 94
Salt-sensitive hypertension is triggered by Ca2+ entry via Na+/Ca2+ exchanger type-1 in vascular smooth muscle
###end article-title 94
###begin article-title 95
###xml 33 38 <span type="species:ncbi:9606">human</span>
Isolation and mapping of a novel human kidney- and liver-specific gene homologous to the bacterial acetyltransferases
###end article-title 95
###begin article-title 96
###xml 30 35 <span type="species:ncbi:9606">human</span>
Changes in gene expression in human renal proximal tubule cells exposed to low concentrations of S-(1,2-dichlorovinyl)-l-cysteine, a metabolite of trichloroethylene
###end article-title 96
###begin article-title 97
Linkage disequilibrium patterns and tagSNP transferability among European populations
###end article-title 97
###begin article-title 98
Web-based global alignment tool CLUSTALW
###end article-title 98
###begin article-title 99
The Primer3 primer designing software
###end article-title 99
###begin article-title 100
National Centre for Biotechnology Information (NCBI BLAST)
###end article-title 100
###begin article-title 101
###xml 44 49 <span type="species:ncbi:9606">Human</span>
Segmental duplications and gene conversion: Human luteinizing hormone/chorionic gonadotropin beta gene cluster
###end article-title 101
###begin article-title 102
North Estonian Blood Center
###end article-title 102
###begin article-title 103
Blood Centre of the Tartu University Clinics
###end article-title 103
###begin article-title 104
Diagnostics Division Laboratory of the North Estonia Medical Centre
###end article-title 104
###begin article-title 105
Estonian Accreditation Centre
###end article-title 105
###begin article-title 106
European co-operation for Accreditation
###end article-title 106
###begin article-title 107
EURACHEM guidelines
###end article-title 107
###begin article-title 108
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification
###end article-title 108
###begin article-title 109
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group
###end article-title 109
###begin article-title 110
Resequencing PNMT in European hypertensive and normotensive individuals: no common susceptibilily variants for hypertension and purifying selection on intron 1
###end article-title 110
###begin article-title 111
The evolution and genomic landscape of CGB1 and CGB2 genes
###end article-title 111
###begin article-title 112
PLINK: a tool set for whole-genome association and population-based linkage analyses
###end article-title 112
###begin article-title 113
Web-based interface for Mann-Whitney two-sided U-test
###end article-title 113
###begin article-title 114
National Centre for Biotechnology Information (NCBI dbSNP database)
###end article-title 114
###begin article-title 115
###xml 80 85 <span type="species:ncbi:9606">human</span>
Evidence for substantial fine-scale variation in recombination rates across the human genome
###end article-title 115
###begin article-title 116
Genomatix company webpage
###end article-title 116
###begin article-title 117
Interplay between estrogen-related receptor alpha (ERRalpha) and gamma (ERRgamma) on the regulation of ERRalpha gene expression
###end article-title 117
###begin article-title 118
The "CholesteROR" protective pathway in the vascular system
###end article-title 118
###begin article-title 119
###xml 86 90 <span type="species:ncbi:10116">rats</span>
High-mobility group box 1 protein promotes development of microvascular thrombosis in rats
###end article-title 119
###begin article-title 120
The regulation of the inflammatory response through nuclear factor-kappab pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases
###end article-title 120
###begin article-title 121
Transcription factor binding site prediction program AliBaba 2.1
###end article-title 121
###begin article-title 122
Actin' together: serum response factor, its cofactors and the link to signal transduction
###end article-title 122
###begin article-title 123
Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio
###end article-title 123
###begin article-title 124
###xml 112 120 <span type="species:ncbi:9606">patients</span>
A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients
###end article-title 124
###begin article-title 125
Associations between CYP11B2 gene polymorphisms and the response to angiotensin-converting enzyme inhibitors
###end article-title 125
###begin article-title 126
Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions
###end article-title 126
###begin article-title 127
Association of a sodium channel alpha subunit promoter variant with blood pressure
###end article-title 127
###begin article-title 128
###xml 36 41 <span type="species:ncbi:9606">human</span>
A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity
###end article-title 128
###begin article-title 129
Assessment of the genetic component of hypertension
###end article-title 129
###begin article-title 130
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human-specific nonsense mutations identified by genome sequence comparisons
###end article-title 130
###begin article-title 131
Genome-wide identification of pseudogenes capable of disease-causing gene conversion
###end article-title 131
###begin article-title 132
###xml 95 98 <span type="species:ncbi:10116">rat</span>
Cytotoxicity of trichloroethylene and S-(1, 2-dichlorovinyl)-L-cysteine in primary cultures of rat renal proximal tubular and distal tubular cells
###end article-title 132
###begin article-title 133
Haem oxygenase-1--a culprit in vascular and renal damage?
###end article-title 133

